Opportunity ID: 275323

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-MH-16-110
Funding Opportunity Title: The Role of Exosomes in HIV Neuropathogenesis (R21)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.242 — Mental Health Research Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 20, 2015
Last Updated Date:
Original Closing Date for Applications: Sep 02, 2015
Current Closing Date for Applications: Sep 02, 2015
Archive Date: Oct 03, 2015
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
County governments
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Independent school districts
State governments
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
City or township governments
Special district governments
Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites small research grant applications focused on defining the central role of exosomes in the neuropathogenesis of Human Immunodeficiency Virus (HIV)-1 Associated Neurocognitive Disorders (HAND) and determining the potential use of exosomes as biomarkers for HAND or as delivery vehicles for CNS targeted therapeutics. Basic and translational research in domestic and international settings is of interest.Multidisciplinary research teams and collaborative alliances are encouraged but not required.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-16-110.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-C FORMS-C PKG00215693 Aug 02, 2015 Sep 02, 2015 View

Package 1

Mandatory forms

275323 RR_SF424_2_0-2.0.pdf

275323 PHS398_ResearchPlan_2_0-2.0.pdf

275323 PHS398_CoverPageSupplement_2_0-2.0.pdf

275323 RR_KeyPersonExpanded_2_0-2.0.pdf

275323 RR_OtherProjectInfo_1_3-1.3.pdf

275323 PerformanceSite_2_0-2.0.pdf

Optional forms

275323 RR_SubawardBudget30_1_3-1.3.pdf

275323 PlannedReport-1.0.pdf

275323 PHS398_CumulativeInclusionReport-1.0.pdf

275323 PHS398_ModularBudget_1_2-1.2.pdf

275323 RR_Budget_1_3-1.3.pdf

2025-07-09T10:23:07-05:00

Share This Post, Choose Your Platform!

About the Author: